Literature DB >> 15009058

A physician's guide to transfusion in autoimmune haemolytic anaemia.

Lawrence D Petz1.   

Abstract

Patients with autoimmune haemolytic anaemia (AIHA) frequently have anaemia of sufficient severity as to require a blood transfusion. However, it is impossible to find compatible blood when, as is frequently the case, the autoantibody in the patient's serum reacts with all normal red blood cells. Further, the autoantibody may mask the presence of a red cell alloantibody capable of causing a haemolytic transfusion reaction. Optimal patient management in this clinical setting requires special compatibility test procedures in the transfusion service laboratory. Equally important is that clinicians must understand the principles of the compatibility tests performed. Provided appropriate compatibility tests are performed, the indications for transfusion in patients with AIHA are not significantly different than for similarly anaemic patients without AIHA. Communication between clinicians and laboratory personnel are important to review the urgency of transfusion and the compatibility test methods used to select the optimal unit of red blood cells for transfusion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009058     DOI: 10.1111/j.1365-2141.2004.04841.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  20 in total

1.  The role of the direct antiglobulin test in pre-transfusion investigations and the approach to selecting blood for transfusion in autoimmune haemolytic anaemia: results of a regional survey.

Authors:  Giancarlo Maria Liumbruno; Adriana Tognaccini; Rosaria Bonini; Giuseppe Curciarello; Isio Masini; Alvaro Ringressi; Francesco Tornabene; Renato Vanacore
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

2.  New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children.

Authors:  Nathalie Aladjidi; Guy Leverger; Thierry Leblanc; Marie Quitterie Picat; Gérard Michel; Yves Bertrand; Brigitte Bader-Meunier; Alain Robert; Brigitte Nelken; Virginie Gandemer; Hélène Savel; Jean Louis Stephan; Fanny Fouyssac; Julien Jeanpetit; Caroline Thomas; Pierre Rohrlich; André Baruchel; Alain Fischer; Geneviève Chêne; Y Perel
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

3.  Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.

Authors:  Inge Baas; Laura Delvasto-Nuñez; Peter Ligthart; Conny Brouwer; Claudia Folman; Edimara S Reis; Daniel Ricklin; John D Lambris; Diana Wouters; Masja de Haas; Ilse Jongerius; Sacha S Zeerleder
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

4.  Understanding therapeutic emergencies in acute hemolysis.

Authors:  David Boutboul; Fabien Touzot; Raphaël Szalat
Journal:  Intensive Care Med       Date:  2017-09-04       Impact factor: 17.440

5.  Autologous Blood Transfusion as a Life Saving Measure for a Trauma Patient with Fracture Femur and Drug Induced Hemolytic Anemia: A Case Report.

Authors:  Sumit Vishwakarma; Rahul Chaurasia; Arulselvi Subramanian; Vivek Trikha; Kabita Chatterjee
Journal:  Indian J Hematol Blood Transfus       Date:  2016-08-25       Impact factor: 0.900

6.  Precautions surrounding blood transfusion in autoimmune haemolytic anaemias are overestimated.

Authors:  Salih Yürek; Beate Mayer; Mohammed Almahallawi; Axel Pruss; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2015-06-16       Impact factor: 3.443

Review 7.  Warm antibody autoimmune hemolytic anemia.

Authors:  Theodosia A Kalfa
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

8.  Immunohematological and Clinical Characterization of Complement and Non-Complement Associated Warm Autoimmune Haemolytic Anemia and Risk Factors Predicting their Occurrences.

Authors:  Sudipta Sekhar Das; Anupam Chakrapani; Soumya Bhattacharya; Rathindra Nath Biswas; Mahammad Safi
Journal:  Indian J Hematol Blood Transfus       Date:  2021-01-19       Impact factor: 0.915

9.  Autoimmune cytopenias and thrombotic thrombocytopenic purpura.

Authors:  Charlotte K Brierley; Sue Pavord
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

10.  Clearance of pathological antibodies using biomimetic nanoparticles.

Authors:  Jonathan A Copp; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Weiwei Gao; Kang Zhang; Liangfang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.